Learn why ADMA Biologics looked undervalued near $2 in 2021—asset value, revenue growth, insider buying, and a path to profitability. Click here to read more.
Touted as India's largest cross-border deal in the financial sector, the Shriram Finance-MUFG deal has been given a thumbs up ...
FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September ...
Gurgaon: With the financial year drawing to a close, MCG accelerated its property tax recovery drive, collecting Rs 30 crore ...
Why the Fair Value Estimate Moved and What It Signals The fair value estimate for Seacoast Banking Corporation of Florida has ...